It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Pancreatoscopy plays a significant role in the diagnosis and treatment of pancreatic diseases. However, the risk of pancreatoscopy is remarkably greater than that of other endoscopic procedures, such as gastroscopy and bronchoscopy, owing to its severe invasiveness. In comparison, virtual pancreatoscopy (VP) has shown notable advantages. However, because of the low resolution of current computed tomography (CT) technology and the small diameter of the pancreatic duct, VP has limited clinical use. In this study, an optimal path algorithm and super-resolution technique are investigated for the development of an open-source software platform for VP based on 3D Slicer. The proposed segmentation of the pancreatic duct from the abdominal CT images reached an average Dice coefficient of 0.85 with a standard deviation of 0.04. Owing to the excellent segmentation performance, a fly-through visualization of both the inside and outside of the duct was successfully reconstructed, thereby demonstrating the feasibility of VP. In addition, a quantitative analysis of the wall thickness and topology of the duct provides more insight into pancreatic diseases than a fly-through visualization. The entire VP system developed in this study is available at https://github.com/gaoyi/VirtualEndoscopy.git.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Health Science Center, Shenzhen University, School of Biomedical Engineering, Shenzhen, China (GRID:grid.263488.3) (ISNI:0000 0001 0472 9649)
2 State University of New York, Laboratory for Imaging Research and Informatics, Stony Brook, USA (GRID:grid.36425.36) (ISNI:0000 0001 2216 9681)
3 Health Science Center, Shenzhen University, School of Biomedical Engineering, Shenzhen, China (GRID:grid.263488.3) (ISNI:0000 0001 0472 9649); Shenzhen Key Laboratory of Precision Medicine for Hematological Malignancies, Shenzhen, China (GRID:grid.263488.3); Marshall Laboratory of Biomedical Engineering, Shenzhen, China (GRID:grid.263488.3); Peng Cheng Laboratory, Shenzhen, China (GRID:grid.508161.b)